FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Hamilton Medical Recalls Ventilators

Hamilton Medical recalls its Hamilton-C1, C2, C3, and T1 ventilators after receiving reports about software issues that may cause the devices to stop ...

latest-news-card-1
Federal Register

Animal Extralabel Drug Use Info Collection

Federal Register notice: FDA seeks comments on an information collection extension entitled Extralabel Drug Use in Animals -- 21 CFR 530.

latest-news-card-1
Federal Register

Info Collection on CVM Dispute Resolutions

Federal Register notice: FDA seeks comments on an information collection extension entitled Dispute Resolution Procedures for Science-Based Decisions ...

latest-news-card-1
Human Drugs

Drug Distribution Security Guidance

FDA publishes a guidance to assist drug supply chain stakeholders to meet the requirements for enhanced drug distribution security at the package leve...

Human Drugs

Drug Tracing Stabilization Period

FDA issues two compliance guidances to implement a one-year stabilization period giving trading partners additional time to meet Drug Supply Chain Sec...

latest-news-card-1
Medical Devices

Comments on Increasing Home Medical Tech Use

Five stakeholders respond to FDA docket questions about expanding home medical technology use.

latest-news-card-1

FDA Renews 5-Year M-CERSI Agreement

FDA approves a five-year $50 million contract renewal with the University of Maryland Center of Excellence in Regulatory Science and Innovation.

latest-news-card-1
Human Drugs

Aion Bio Temperature Monitor Cleared

FDA clears an Aion Biosystems 510 (k) for its iTempShield device and software system for continuous measurement of body temperature.

latest-news-card-1
Biologics

Abeona Plans BLA for Cell Therapy

Abeona Therapeutics plans to file a BLA for EB-101, a cell therapy for patients with recessive dystrophic epidermolysis bullosa, after a pre-BLA meeti...

latest-news-card-1
Medical Devices

Breakthrough Designation for Quest Diagnostic

FDA grants Quest Diagnostics a breakthrough device designation for its AAVrh74 ELISA assay for identifying Duchenne muscular dystrophy patients eligib...